Karyopharm Therapeutics Inc. (55) | Purchase Agreements (2)
- Securities Purchase Agreement, dated December 5, 2022, by and among the Company and the other parties thereto (Filed With SEC on December 5, 2022)
- Amendment to Asset Purchase Agreement, dated as of July 17, 2019, by and between the Registrant and Biogen MA Inc (Filed With SEC on November 3, 2021)
